세계의 독소 시장예측 2021년-2026년

■ 영문 제목 : Global Toxin Market Growth 2021-2026

LP Information가 발행한 조사보고서이며, 코드는 LPI-2201K02203 입니다.■ 상품코드 : LPI-2201K02203
■ 조사/발행회사 : LP Information
■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.)
■ 페이지수 : 99
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일
■ 조사대상 지역 : 글로벌
■ 산업 분야 : 의약품
■ 판매가격 / 옵션 (부가세 10% 별도)
Single User (1명 열람용)USD3,660 ⇒환산₩5,124,000견적의뢰/주문/질문
Multi User (5명 열람용)USD5,490 ⇒환산₩7,686,000견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)USD7,320 ⇒환산₩10,248,000견적의뢰/구입/질문
가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
본 조사보고서는 독소의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (50U, 100U, 기타)와 용도별 시장규모 (의료, 화장품) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 독소 시장 점유율
- 지역별 독소 시장규모
- 주요지역의 종류별 시장규모 (50U, 100U, 기타)
- 주요지역의 용도별 시장규모 (의료, 화장품)
- 미주의 독소 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 독소 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 독소 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 독소 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 독소 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Allergan, Ipsen, Medytox, LIBP, Merz Pharmaceuticals, US World Meds, Hugel, Daewoong
- 조사의 결과/결론
■ 보고서 개요

According to this latest study, the 2021 growth of Toxin will have significant change from previous year. By the most conservative estimates of global Toxin market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 4269.1 million in 2020. Over the next five years the Toxin market will register a 10.2% CAGR in terms of revenue, the global market size will reach US$ 6285.9 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Toxin market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
50U
100U
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Medical
Cosmetic

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Allergan
Ipsen
Medytox
LIBP
Merz Pharmaceuticals
US World Meds
Hugel
Daewoong

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Toxin Consumption 2016-2026
2.1.2 Toxin Consumption CAGR by Region
2.2 Toxin Segment by Type
2.2.1 50U
2.2.2 100U
2.2.3 Others
2.3 Toxin Sales by Type
2.3.1 Global Toxin Sales Market Share by Type (2016-2021)
2.3.2 Global Toxin Revenue and Market Share by Type (2016-2021)
2.3.3 Global Toxin Sale Price by Type (2016-2021)
2.4 Toxin Segment by Application
2.4.1 Medical
2.4.2 Cosmetic
2.5 Toxin Sales by Application
2.5.1 Global Toxin Sale Market Share by Application (2016-2021)
2.5.2 Global Toxin Revenue and Market Share by Application (2016-2021)
2.5.3 Global Toxin Sale Price by Application (2016-2021)

3 Global Toxin by Company
3.1 Global Toxin Sales Market Share by Company
3.1.1 Global Toxin Sales by Company (2019-2021)
3.1.2 Global Toxin Sales Market Share by Company (2019-2021)
3.2 Global Toxin Revenue Market Share by Company
3.2.1 Global Toxin Revenue by Company (2019-2021)
3.2.2 Global Toxin Revenue Market Share by Company (2019-2021)
3.3 Global Toxin Sale Price by Company
3.4 Global Manufacturers Toxin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Toxin Product Location Distribution
3.4.2 Players Toxin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Toxin by Region
4.1 Global Toxin by Region
4.1.1 Global Toxin Sales by Region
4.1.2 Global Toxin Revenue by Region
4.2 Americas Toxin Sales Growth
4.3 APAC Toxin Sales Growth
4.4 Europe Toxin Sales Growth
4.5 Middle East & Africa Toxin Sales Growth

5 Americas
5.1 Americas Toxin Sales by Country
5.1.1 Americas Toxin Sales by Country (2016-2021)
5.1.2 Americas Toxin Revenue by Country (2016-2021)
5.2 Americas Toxin Sales by Type
5.3 Americas Toxin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Toxin Sales by Region
6.1.1 APAC Toxin Sales by Region (2016-2021)
6.1.2 APAC Toxin Revenue by Region (2016-2021)
6.2 APAC Toxin Sales by Type
6.3 APAC Toxin Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Toxin by Country
7.1.1 Europe Toxin Sales by Country (2016-2021)
7.1.2 Europe Toxin Revenue by Country (2016-2021)
7.2 Europe Toxin Sales by Type
7.3 Europe Toxin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Toxin by Country
8.1.1 Middle East & Africa Toxin Sales by Country (2016-2021)
8.1.2 Middle East & Africa Toxin Revenue by Country (2016-2021)
8.2 Middle East & Africa Toxin Sales by Type
8.3 Middle East & Africa Toxin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Toxin Distributors
10.3 Toxin Customer

11 Global Toxin Market Forecast
11.1 Global Toxin Forecast by Region
11.1.1 Global Toxin Forecast by Regions (2021-2026)
11.2.2 Global Toxin Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Toxin Forecast by Type
11.7 Global Toxin Forecast by Application

12 Key Players Analysis
12.1 Allergan
12.1.1 Allergan Company Information
12.1.2 Allergan Toxin Product Offered
12.1.3 Allergan Toxin Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Allergan Main Business Overview
12.1.5 Allergan Latest Developments
12.2 Ipsen
12.2.1 Ipsen Company Information
12.2.2 Ipsen Toxin Product Offered
12.2.3 Ipsen Toxin Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Ipsen Main Business Overview
12.2.5 Ipsen Latest Developments
12.3 Medytox
12.3.1 Medytox Company Information
12.3.2 Medytox Toxin Product Offered
12.3.3 Medytox Toxin Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Medytox Main Business Overview
12.3.5 Medytox Latest Developments
12.4 LIBP
12.4.1 LIBP Company Information
12.4.2 LIBP Toxin Product Offered
12.4.3 LIBP Toxin Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 LIBP Main Business Overview
12.4.5 LIBP Latest Developments
12.5 Merz Pharmaceuticals
12.5.1 Merz Pharmaceuticals Company Information
12.5.2 Merz Pharmaceuticals Toxin Product Offered
12.5.3 Merz Pharmaceuticals Toxin Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Merz Pharmaceuticals Main Business Overview
12.5.5 Merz Pharmaceuticals Latest Developments
12.6 US World Meds
12.6.1 US World Meds Company Information
12.6.2 US World Meds Toxin Product Offered
12.6.3 US World Meds Toxin Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 US World Meds Main Business Overview
12.6.5 US World Meds Latest Developments
12.7 Hugel
12.7.1 Hugel Company Information
12.7.2 Hugel Toxin Product Offered
12.7.3 Hugel Toxin Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Hugel Main Business Overview
12.7.5 Hugel Latest Developments
12.8 Daewoong
12.8.1 Daewoong Company Information
12.8.2 Daewoong Toxin Product Offered
12.8.3 Daewoong Toxin Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Daewoong Main Business Overview
12.8.5 Daewoong Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Toxin Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of 50U
Table 3. Major Players of 100U
Table 4. Major Players of Others
Table 5. Global Toxin Sales by Type (2016-2021) & (K Vial)
Table 6. Global Toxin Sales Market Share by Type (2016-2021)
Table 7. Global Toxin Revenue by Type (2016-2021) & ($ million)
Table 8. Global Toxin Revenue Market Share by Type (2016-2021)
Table 9. Global Toxin Sale Price by Type (2016-2021)
Table 10. Global Toxin Sales by Application (2016-2021) & (K Vial)
Table 11. Global Toxin Sales Market Share by Application (2016-2021)
Table 12. Global Toxin Value by Application (2016-2021)
Table 13. Global Toxin Revenue Market Share by Application (2016-2021)
Table 14. Global Toxin Sale Price by Application (2016-2021)
Table 15. Global Toxin Sales by Company (2019-2021) & (K Vial)
Table 16. Global Toxin Sales Market Share by Company (2019-2021)
Table 17. Global Toxin Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Toxin Revenue Market Share by Company (2019-2021)
Table 19. Global Toxin Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Toxin Producing Area Distribution and Sales Area
Table 21. Players Toxin Products Offered
Table 22. Toxin Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Toxin Sales by Region (2016-2021) (K Vial)
Table 26. Global Toxin Sales Market Share by Region (2016-2021)
Table 27. Global Toxin Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Toxin Revenue Market Share by Region (2016-2021)
Table 29. Americas Toxin Sales by Country (2016-2021) & (K Vial)
Table 30. Americas Toxin Sales Market Share by Country (2016-2021)
Table 31. Americas Toxin Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Toxin Revenue Market Share by Country (2016-2021)
Table 33. Americas Toxin Sales by Type (2016-2021) & (K Vial)
Table 34. Americas Toxin Sales Market Share by Type (2016-2021)
Table 35. Americas Toxin Sales by Application (2016-2021) & (K Vial)
Table 36. Americas Toxin Sales Market Share by Application (2016-2021)
Table 37. APAC Toxin Sales by Region (2016-2021) & (K Vial)
Table 38. APAC Toxin Sales Market Share by Region (2016-2021)
Table 39. APAC Toxin Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Toxin Revenue Market Share by Region (2016-2021)
Table 41. APAC Toxin Sales by Type (2016-2021) & (K Vial)
Table 42. APAC Toxin Sales Market Share by Type (2016-2021)
Table 43. APAC Toxin Sales by Application (2016-2021) & (K Vial)
Table 44. APAC Toxin Sales Market Share by Application (2016-2021)
Table 45. Europe Toxin Sales by Country (2016-2021) & (K Vial)
Table 46. Europe Toxin Sales Market Share by Country (2016-2021)
Table 47. Europe Toxin Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Toxin Revenue Market Share by Country (2016-2021)
Table 49. Europe Toxin Sales by Type (2016-2021) & (K Vial)
Table 50. Europe Toxin Sales Market Share by Type (2016-2021)
Table 51. Europe Toxin Sales by Application (2016-2021) & (K Vial)
Table 52. Europe Toxin Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Toxin Sales by Country (2016-2021) & (K Vial)
Table 54. Middle East & Africa Toxin Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Toxin Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Toxin Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Toxin Sales by Type (2016-2021) & (K Vial)
Table 58. Middle East & Africa Toxin Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Toxin Sales by Application (2016-2021) & (K Vial)
Table 60. Middle East & Africa Toxin Sales Market Share by Application (2016-2021)
Table 61. Key and Potential Regions of Toxin
Table 62. Key Application and Potential Industries of Toxin
Table 63. Key Challenges of Toxin
Table 64. Key Trends of Toxin
Table 65. Toxin Distributors List
Table 66. Toxin Customer List
Table 67. Global Toxin Sales Forecast by Region (2021-2026) & (K Vial)
Table 68. Global Toxin Consumption Market Forecast by Region
Table 69. Global Toxin Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Toxin Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Toxin Sales Forecast by Country (2021-2026) & (K Vial)
Table 72. Americas Toxin Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Toxin Sales Forecast by Region (2021-2026) & (K Vial)
Table 74. APAC Toxin Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Toxin Sales Forecast by Country (2021-2026) & (K Vial)
Table 76. Europe Toxin Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Toxin Sales Forecast by Country (2021-2026) & (K Vial)
Table 78. Middle East & Africa Toxin Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Toxin Sales Forecast by Type (2021-2026) & (K Vial)
Table 80. Global Toxin Sales Market Share Forecast by Type (2021-2026)
Table 81. Global Toxin Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global Toxin Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global Toxin Sales Forecast by Application (2021-2026) & (K Vial)
Table 84. Global Toxin Sales Market Share Forecast by Application (2021-2026)
Table 85. Global Toxin Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 86. Global Toxin Revenue Market Share Forecast by Application (2021-2026)
Table 87. Allergan Basic Information, Toxin Manufacturing Base, Sales Area and Its Competitors
Table 88. Allergan Toxin Product Offered
Table 89. Allergan Toxin Sales (K Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2019-2021E)
Table 90. Allergan Main Business
Table 91. Allergan Latest Developments
Table 92. Ipsen Basic Information, Toxin Manufacturing Base, Sales Area and Its Competitors
Table 93. Ipsen Toxin Product Offered
Table 94. Ipsen Toxin Sales (K Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2019-2021E)
Table 95. Ipsen Main Business
Table 96. Ipsen Latest Developments
Table 97. Medytox Basic Information, Toxin Manufacturing Base, Sales Area and Its Competitors
Table 98. Medytox Toxin Product Offered
Table 99. Medytox Toxin Sales (K Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2019-2021E)
Table 100. Medytox Main Business
Table 101. Medytox Latest Developments
Table 102. LIBP Basic Information, Toxin Manufacturing Base, Sales Area and Its Competitors
Table 103. LIBP Toxin Product Offered
Table 104. LIBP Toxin Sales (K Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2019-2021E)
Table 105. LIBP Main Business
Table 106. LIBP Latest Developments
Table 107. Merz Pharmaceuticals Basic Information, Toxin Manufacturing Base, Sales Area and Its Competitors
Table 108. Merz Pharmaceuticals Toxin Product Offered
Table 109. Merz Pharmaceuticals Toxin Sales (K Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2019-2021E)
Table 110. Merz Pharmaceuticals Main Business
Table 111. Merz Pharmaceuticals Latest Developments
Table 112. US World Meds Basic Information, Toxin Manufacturing Base, Sales Area and Its Competitors
Table 113. US World Meds Toxin Product Offered
Table 114. US World Meds Toxin Sales (K Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2019-2021E)
Table 115. US World Meds Main Business
Table 116. US World Meds Latest Developments
Table 117. Hugel Basic Information, Toxin Manufacturing Base, Sales Area and Its Competitors
Table 118. Hugel Toxin Product Offered
Table 119. Hugel Toxin Sales (K Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2019-2021E)
Table 120. Hugel Main Business
Table 121. Hugel Latest Developments
Table 122. Daewoong Basic Information, Toxin Manufacturing Base, Sales Area and Its Competitors
Table 123. Daewoong Toxin Product Offered
Table 124. Daewoong Toxin Sales (K Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2019-2021E)
Table 125. Daewoong Main Business
Table 126. Daewoong Latest Developments
List of Figures
Figure 1. Picture of Toxin
Figure 2. Toxin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Toxin Sales Growth Rate 2016-2026 (K Vial)
Figure 7. Global Toxin Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Toxin Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of 50U
Figure 10. Product Picture of 100U
Figure 11. Product Picture of Others
Figure 12. Global Toxin Sales Market Share by Type in 2020
Figure 13. Global Toxin Revenue Market Share by Type (2016-2021)
Figure 14. Toxin Consumed in Medical
Figure 15. Global Toxin Market: Medical (2016-2021) & (K Vial)
Figure 16. Toxin Consumed in Cosmetic
Figure 17. Global Toxin Market: Cosmetic (2016-2021) & (K Vial)
Figure 18. Global Toxin Sales Market Share by Application (2016-2021)
Figure 19. Global Toxin Revenue Market Share by Application in 2020
Figure 20. Toxin Revenue Market by Company in 2020 ($ Million)
Figure 21. Global Toxin Revenue Market Share by Company in 2020
Figure 22. Global Toxin Sales Market Share by Regions (2016-2021)
Figure 23. Global Toxin Revenue Market Share by Region in 2020
Figure 24. Americas Toxin Sales 2016-2021 (K Vial)
Figure 25. Americas Toxin Revenue 2016-2021 ($ Millions)
Figure 26. APAC Toxin Sales 2016-2021 (K Vial)
Figure 27. APAC Toxin Revenue 2016-2021 ($ Millions)
Figure 28. Europe Toxin Sales 2016-2021 (K Vial)
Figure 29. Europe Toxin Revenue 2016-2021 ($ Millions)
Figure 30. Middle East & Africa Toxin Sales 2016-2021 (K Vial)
Figure 31. Middle East & Africa Toxin Revenue 2016-2021 ($ Millions)
Figure 32. Americas Toxin Sales Market Share by Country in 2020
Figure 33. Americas Toxin Revenue Market Share by Country in 2020
Figure 34. Americas Toxin Sales Market Share by Type in 2020
Figure 35. Americas Toxin Sales Market Share by Application in 2020
Figure 36. United States Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 37. Canada Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 38. Mexico Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 39. Brazil Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 40. APAC Toxin Sales Market Share by Region in 2020
Figure 41. APAC Toxin Revenue Market Share by Regions in 2020
Figure 42. APAC Toxin Sales Market Share by Type in 2020
Figure 43. APAC Toxin Sales Market Share by Application in 2020
Figure 44. China Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 45. Japan Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 46. Korea Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 47. Southeast Asia Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 48. India Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 49. Australia Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 50. Europe Toxin Sales Market Share by Country in 2020
Figure 51. Europe Toxin Revenue Market Share by Country in 2020
Figure 52. Europe Toxin Sales Market Share by Type in 2020
Figure 53. Europe Toxin Sales Market Share by Application in 2020
Figure 54. Germany Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 55. France Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 56. UK Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 57. Italy Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 58. Russia Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 59. Middle East & Africa Toxin Sales Market Share by Country in 2020
Figure 60. Middle East & Africa Toxin Revenue Market Share by Country in 2020
Figure 61. Middle East & Africa Toxin Sales Market Share by Type in 2020
Figure 62. Middle East & Africa Toxin Sales Market Share by Application in 2020
Figure 63. Egypt Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 64. South Africa Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 65. Israel Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 66. Turkey Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 67. GCC Country Toxin Revenue Growth 2016-2021 ($ Millions)
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
※본 조사보고서 [세계의 독소 시장예측 2021년-2026년] (코드 : LPI-2201K02203) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [세계의 독소 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.
※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!